Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Science Translational Medicine|April 21, 2012
The power of oneDaniel Louvard, François Sigaux, Sylvie Robine
European Journal of Immunology|January 31, 2003
Disruption of the lineage restriction of TCR beta gene rearrangementsStéphanie Eyquem, Chantal Lagresle, Magali Fasseu, et al.
Leukemia Research|October 3, 2009
Genetic inactivation of Ikaros is a rare event in human T-ALLAmbroise Marçais, Robin Jeannet, Lucie Hernandez, et al.
European Journal of Immunology|September 24, 2004
The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factorStéphanie Eyquem, Karine Chemin, Magali Fasseu, et al.
Biochemical and Biophysical Research Communications|November 16, 2004
Repression of transcription at the human T-cell receptor Vbeta2.2 segment is mediated by a MAX/MAD/mSin3 complex acting as a scaffold for HDAC activityMarie-Pierre Font, Myriam Cubizolles, Hervé Dombret, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 11, 2003
Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphomaSophie Park, Maria-Elena Noguera, Josette Brière, et al.
BMC Genomics|March 17, 2006
Comparison of the latest commercial short and long oligonucleotide microarray technologiesAurélien de Reyniès, Daniela Geromin, Jean-Michel Cayuela, et al.
British Journal of Haematology|April 26, 2002
In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemiaChristian Récher, Martine Chopin, Emmanuel Raffoux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytesChantal Lagresle, Betty Gardie, Stéphanie Eyquem, et al.
The Journal of Biological Chemistry|March 30, 2012
α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK)Dalila Naci, Mohammed-Amine El Azreq, Nizar Chetoui, et al.
Pageof 4